Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Hemostasis
•
Hematology
•
Benign Hematology
•
Hemophilia
What is your recommended management algorithm for bleeding associated with an acquired factor VIII inhibitor?
Answer from: at Community Practice
Fragner et al., Cureus 2022.
Sign in or Register to read more
12811
Related Questions
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
Can TPO agonists, like avatrombopag or lusutrombopag, be used for patients with chronic thrombocytopenia and new acute portal vein thrombosis?
In light of the Haven 7 trial results, what considerations should be made regarding the monitoring and management of potential long-term adverse effects of emicizumab in infants?
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
How do you treat factor XI deficient patients with surgery or trauma related bleeding?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
Are there data to support full-dose anticoagulation added to an antiplatelet in recurrent peripheral arterial thrombosis requiring revascularization and stenting?
What workup do you perform for elevated B12 levels in an adult who is not taking supplements?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?